Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum Leprosum
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
Study 2B: Ciclosporin in the management of chronic or recurrent Erythema Nodosum Leprosum
Aim: To assess the safety, tolerability and efficacy of Ciclosporin in the treatment of
patients whose ENL is not controlled with standard Prednisolone.
Objective: A pilot double blind controlled study randomizing patients whose ENL is not
controlled with standard Prednisolone, and comparing a group treated with Ciclosporin to a
group treated with additional steroid only.
Phase:
Phase 2
Details
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborators:
Alert Hospital, Ethiopia Armauer Hansen Research Institute, Ethiopia Homes and Hospitals of St Giles